$9.46 Million is the total value of CROSSPOINT FINANCIAL, LLC's 9 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKB | BERKSHIRE HATHAWAY INC DELcl b new | $3,014,335 | +2.7% | 8,605 | 0.0% | 31.86% | +6.7% | |
| FIRST TR EXCHNG TRADED FD VIft cboe vest us | $763,536 | -1.0% | 23,050 | 0.0% | 8.07% | +2.9% | ||
| FB | META PLATFORMS INCcl a | $325,729 | +4.6% | 1,085 | 0.0% | 3.44% | +8.7% | |
| ALLO | ALLOGENE THERAPEUTICS INC | $38,040 | -36.2% | 12,000 | 0.0% | 0.40% | -33.8% | |
| MICROVAST HOLDINGS INC*w exp 04/01/202 | $1,950 | -4.9% | 10,000 | 0.0% | 0.02% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 4 | Q3 2023 | 31.9% |
| ETF SER SOLUTIONS | 4 | Q3 2023 | 24.5% |
| VANECK ETF TRUST | 4 | Q3 2023 | 17.1% |
| ISHARES TR | 4 | Q3 2023 | 15.4% |
| FIRST TR EXCHNG TRADED FD VI | 4 | Q3 2023 | 8.1% |
| ISHARES GOLD TR | 4 | Q3 2023 | 8.1% |
| MICROVAST HOLDINGS INC | 4 | Q3 2023 | 0.0% |
| META PLATFORMS INC | 3 | Q3 2023 | 3.4% |
| TERNS PHARMACEUTICALS INC | 3 | Q2 2023 | 1.7% |
| ALLOGENE THERAPEUTICS INC | 2 | Q3 2023 | 0.6% |
View CROSSPOINT FINANCIAL, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-24 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-08 |
View CROSSPOINT FINANCIAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.